Antibacterial Susceptibility Testing of in Acne Vulgaris Patients.

Introduction: Combination therapy is widely used for the treatment of acne vulgaris (AV), including local anti-inflammatory drugs containing antimicrobials, such as clindamycin or erythromycin, to inhibit () growth and at the same time reduce the production of inflammatory mediators. The aim of the study is to compare the antibacterial susceptibility of to clindamycin and erythromycin in AV patients compared with healthy patients in the control group (CG).

Methods: The prospective study included 56 patients with clinically diagnosed AV symptoms and 12 patients were included in the CG who did not have AV.